Director · LIGAND PHARMACEUTICALS INC · LIGAND PHARMACEUTICALS INC — Non-Qualified Stock Option (right to buy)
Side
M
Value
—
Shares
2,145
Price
—
Executed
Nov 7, 2025
Disclosed
Nov 12, 2025
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Nov 7 executedNov 12, 2025 disclosed
LGND · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
LIGAND PHARMACEUTICALS INC — Non-Qualified Stock Option (right to buy)
Ticker
LGND
Shares
2,145
Price per share
$0
Execution date (reported)
Nov 7, 2025
Owned after transaction
0 shares
Days from execution to publication
5
What this establishes
Lamattina John L filed this Form 4 reporting a option exercise of LGND on Nov 7, 2025. It became public on Nov 12, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Lamattina John Lcik:0001216074
Issuer
LIGAND PHARMACEUTICALS INCcik:0000886163
Revision history · 0
No field has changed since this record was first ingested.
